ClinicalTrials.Veeva

Menu

Platelet Rich Plasma in Women With Urinary Incontinence

N

National and Kapodistrian University of Athens

Status and phase

Unknown
Phase 3
Phase 2

Conditions

Stress Urinary Incontinence
Urinary Incontinence

Treatments

Other: Normal Saline Injections
Biological: Platelet Rich Plasma Injections

Study type

Interventional

Funder types

Other

Identifiers

NCT05112718
420/20-09-2019

Details and patient eligibility

About

Stress urinary incontinence (SUI) is defined as involuntary loss of urine on effort or physical exertion or on sneezing or coughing. Platelet-rich plasma (PRP) is an autologous solution of human plasma containing various growth factors witch enhance regeneration and healing process. The aim of this study is to evaluate the efficacy and safety of PRP in the treatment of the female SUI.

Enrollment

50 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult women with stress urinary incontinence

Exclusion criteria

  • pregnancy,
  • history of active malignant pathology,
  • mental disorders making them unable to give consent,
  • undiagnosed abnormal uterine bleeding,
  • genitourinary fistula,
  • anti-incontinence surgery,
  • pelvic organ prolapse stage > 2 according to POP-Q system

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

50 participants in 2 patient groups

Platelet Rich Plasma
Experimental group
Description:
The patients who receive PRP injections
Treatment:
Biological: Platelet Rich Plasma Injections
Normal Saline
Sham Comparator group
Description:
The patients who receive normal saline
Treatment:
Other: Normal Saline Injections

Trial contacts and locations

1

Loading...

Central trial contact

Stavros Athanasiou, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems